Michelangelo Fiorentino

Immunohistochemical Expression of Preferentially Expressed Antigen in Melanoma (PRAME) in the Uninvolved Background Testis, Germ Cell Neoplasia In Situ, and Germ Cell Tumors of the Testis.

Ricci C, Franceschini T, Giunchi F, Grillini M, Ambrosi F, Massari F, Mollica V, Colecchia M, Fiorentino M.

Am J Clin Pathol. 2022 05 04. 157(5):644-648. PMID: 34864837

Interobserver agreement of PD-L1 (SP263) assessment in advanced NSCLC on cytological smears and histological samples.

Ambrosi F, Giunchi F, Capizzi E, Cancellieri A, Trisolini R, Ardizzoni A, Fiorentino M, Ricci C.

Pathol Res Pract. 2022 May. 233:153893. PMID: 35429890

Hematoxylin and eosin or double stain for CD34/SOX10: Which is better for the detection of lymphovascular invasion in cutaneous melanoma?

Ricci C, Dika E, Lambertini M, Ambrosi F, Grillini M, Chillotti S, Corradini AG, Veronesi G, Fiorentino M, Corti B.

Pathol Res Pract. 2022 May. 233:153876. PMID: 35390633

The EORTC protocol for sentinel lymph node biopsy (SLNB) reveals a high number of nodal nevi and a strong association with nevus-associated melanoma.

Ricci C, Dika E, Lambertini M, Ambrosi F, Chiarucci F, Chillotti S, Fiorentino M, Fabbri E, Tassone D, Veronesi G, Tartari F, Corti B.

Pathol Res Pract. 2022 May. 233:153805. PMID: 35361504

The role of MRI in the detection of local recurrence: Added value of multiparametric approach and Signal Intensity/Time Curve analysis.

Gaudiano C, Ciccarese F, Bianchi L, Corcioni B, De Cinque A, Giunchi F, Schiavina R, Fiorentino M, Brunocilla E, Golfieri R.

Arch Ital Urol Androl. 2022 Mar 28. 94(1):25-31. PMID: 35352521

Intra-epithelial non-canonical Activin A signaling safeguards prostate progenitor quiescence.

Cambuli F, Foletto V, Alaimo A, De Felice D, Gandolfi F, Palumbieri MD, Zaffagni M, Genovesi S, Lorenzoni M, Celotti M, Bertossio E, Mazzero G, Bertossi A, Bisio A, Berardinelli F, Antoccia A, Gaspari M, Barbareschi M, Fiorentino M, Shen MM, Loda M, Romanel A, Lunardi A.

EMBO Rep. 2022 May 04. 23(5):e54049. PMID: 35253958

PI-RADS version 2.1 for the evaluation of transition zone lesions: a practical guide for radiologists.

Gaudiano C, Rustici A, Corcioni B, Ciccarese F, Bianchi L, Schiavina R, Giunchi F, Fiorentino M, Brunocilla E, Golfieri R.

Br J Radiol. 2022 Mar 01. 95(1131):20210916. PMID: 34919421

Prognostic Utility of the Gleason Grading System Revisions and Histopathological Factors Beyond Gleason Grade.

Zelic R, Giunchi F, Fridfeldt J, Carlsson J, Davidsson S, Lianas L, Mascia C, Zugna D, Molinaro L, Vincent PH, Zanetti G, Andrén O, Richiardi L, Akre O, Fiorentino M, Pettersson A.

Clin Epidemiol. 2022. 14:59-70. PMID: 35082531

Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate data.

Ricci AD, Rizzo A, Mollica V, Schiavina R, Fiorentino M, Brunocilla E, Ardizzoni A, Massari F.

Anticancer Drugs. 2022 01 01. 33(1):e61-e68. PMID: 34387596

HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME).

Grillini M, Ricci C, Pino V, Pedrini S, Fiorentino M, Corti B.

Appl Immunohistochem Mol Morphol. 2022 01 01. 30(1):14-18. PMID: 34508017